BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9161752)

  • 21. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries.
    Ohlmann P; Martínez MC; Schneider F; Stoclet JC; Andriantsitohaina R
    Br J Pharmacol; 1997 Jun; 121(4):657-64. PubMed ID: 9208131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo effects of halothane, enflurane, and isoflurane on hepatic sinusoidal microcirculation.
    Grundmann U; Zissis A; Bauer C; Bauer M
    Acta Anaesthesiol Scand; 1997 Jun; 41(6):760-5. PubMed ID: 9241339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelium-derived relaxing factor release associated with increased endothelial cell inositol trisphosphate and intracellular calcium.
    Loeb AL; Izzo NJ; Johnson RM; Garrison JC; Peach MJ
    Am J Cardiol; 1988 Oct; 62(11):36G-40G. PubMed ID: 3263034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
    Korenaga R
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Close correlation between cytoplasmic Ca++ levels and release of an endothelium-derived relaxing factor from cultured endothelial cells.
    Korenaga R; Ando J; Ohtsuka A; Sakuma I; Yang W; Toyo-oka T; Kamiya A
    Cell Struct Funct; 1993 Apr; 18(2):95-104. PubMed ID: 8364982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of endothelium-derived relaxing factor from freshly harvested porcine endothelial cells.
    Hartmann A; Saeed M; Bing RJ
    Circ Res; 1987 Oct; 61(4):548-54. PubMed ID: 3498557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelium-derived relaxing factor is not responsible for inhibition of hypoxic pulmonary vasoconstriction by inhalational anesthetics.
    Marshall C; Marshall BE
    Anesthesiology; 1990 Sep; 73(3):441-8. PubMed ID: 2393128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Parker JL; Tanner MA; Adams HR
    Shock; 1994 Jan; 1(1):73-8. PubMed ID: 7743332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
    Chin JH; Azhar S; Hoffman BB
    J Clin Invest; 1992 Jan; 89(1):10-8. PubMed ID: 1309534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The half-life of endothelium-derived relaxing factor released from bovine aortic endothelial cells in culture.
    Angus JA; Cocks TM
    J Physiol; 1987 Jul; 388():71-81. PubMed ID: 3498834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
    D'Orleans-Juste P; Mitchell JA; Wood EG; Hecker M; Vane JR
    Can J Physiol Pharmacol; 1992 May; 70(5):687-94. PubMed ID: 1423010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
    Kondo K; Mitchell JA; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Oct; 98(2):630-6. PubMed ID: 2573403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EDRF generation and release from perfused bovine pulmonary artery and vein.
    Ignarro LJ; Buga GM; Chaudhuri G
    Eur J Pharmacol; 1988 Apr; 149(1-2):79-88. PubMed ID: 3135198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells.
    Mülsch A; Böhme E; Busse R
    Eur J Pharmacol; 1987 Mar; 135(2):247-50. PubMed ID: 2884122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.